Evidence map›Paper›PMID 21245619›Full record

ArticleThe Indian journal of medical research2010

Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India.

Shruti H Mehta, Samantha L Vogt, Aylur K Srikrishnan, Conjeevaram K Vasudevan, Kalilapuri G Murugavel, Shanmugam Saravanan, Santhanam Anand, M Suresh Kumar, Stuart C Ray, David D Celentano and 2 more

Open access · greenAbstract read
In one paragraph

Article in The Indian journal of medical research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Assessment of clinical co-morbidities.Indian journal of psychiatry · 2018
    Review
  9. Tackling the Hepatitis C Disease Burden in Punjab, India.Journal of clinical and experimental hepatology · 2016
    Review
  10. Article
  11. Drug Abuse, HIV, and HCV in Asian Countries.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2016
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. A new era in the treatment of chronic hepatitis C infection.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2013
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Shruti H MehtaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. shmehta@jhsph.edu
Samantha L Vogt
Aylur K Srikrishnan
Conjeevaram K Vasudevan
Kalilapuri G Murugavel
Shanmugam Saravanan
Santhanam Anand
M Suresh Kumar
Stuart C Ray
David D Celentano
Suniti Solomon
Sunil S Solomon
YR Gaitonde Centre for AIDS Research and Education · INJohns Hopkins University · US

Funding

TUBERCULOSIS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW000010 · FIC · JOHNS HOPKINS UNIVERSITY · PI BEYRER, CHRISTOPHER C. · 1988 to 2012
$19.8M
INCIDENCE OF HIV INFECTIONS IN A COHORT OF IV DRUG USERSR01DA012568 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MEHTA, SHRUTI H · 1999 to 2017
$15.5M
Mechanisms of Hepatitis C Virus EvolutionR01DA024565 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RAY, STUART C · 2007 to 2011
$2.6M
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERSR56DA012568 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MEHTA, SHRUTI H · 2013 to 2013
$833k
FIC NIH HHS 2D 43 TW000010-23 AITRPNIDA NIH HHS DA024565NIDA NIH HHS DA12568NIDA NIH HHS R01 DA012568NIDA NIH HHS R01 DA024565NIDA NIH HHS R56 DA012568
6 · The paper itself

Abstract

BACKGROUND AND

objectivesWe characterized HCV antibody prevalence, viral persistence, genotype and liver disease prevalence among IDUs in Chennai, India as the study of the association of HIV with each of these states is important and there are no data available.

methodsBetween 2005-2006, 1158 IDUs were recruited and followed semi-annually. All were tested for HCV antibodies at baseline; a random sample of 400 antibody positives (200 HIV-positive and 200 HIV-negative) were tested for HCV RNA; 13 of these were sequenced. Assessment of asparate amino transferase (AST)-to-platelet ratio index (APRI) was done on 557 IDUs. Prevalence ratios of each outcome were examined.

resultsMedian age was 35 yr; 99 per cent were male. HCV antibody prevalence was 55 per cent and was associated with older age, being unmarried, longer injection history, tattoo and injecting at a dealer's place. Of the 400 HCV antibody positive IDUs, 281 (70.3%) had persistent infection which was less common among hepatitis B-infected persons but not associated with HIV. Of the 13 samples sequenced, 11 (85%) were HCV genotype 3a. Fibrosis prevalence according to APRI was: HIV/HCV-uninfected, 4 per cent; HIV mono-infected, 3 per cent; HCV mono-infected, 11 per cent; HIV/HCV co-infected, 12 per cent (P<0.001). In addition to being associated with HCV and HIV/HCV, fibrosis prevalence was higher among those drinking alcohol frequently; daily marijuana use was protective. INTERPRETATION AND

conclusionsOur findings show that IDUs in Chennai have high HCV prevalence and associated disease burden. The burden will increase as access to antiretroviral therapy improves particularly given the high prevalence of HIV, HCV and alcohol use.

Indexed as

AdultAntibodies, ViralAspartate AminotransferasesBlood PlateletsCohort StudiesDrug UsersGenotypeHepacivirusHepatitis CHumansIndiaLiver CirrhosisMalePrevalenceProspective StudiesRNA, ViralAntibodies, ViralAspartate AminotransferasesRNA, Viral

Identifiers

PMID21245619
PMCPMC3102459
OpenAlexW2096497201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.